Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings

The hemostatic properties of recombinant activated factor VII (rFVIIa) are established in patients with inherited or acquired hemophilia with inhibitors and in patients with congenital factor VII deficiencies. Emerging clinical evidence suggests that there may be a wider role for rFVIIa in the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Grounds, R Michael, Bolan, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226121/
https://www.ncbi.nlm.nih.gov/pubmed/16221317
http://dx.doi.org/10.1186/cc3783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226121/
https://www.ncbi.nlm.nih.gov/pubmed/16221317
http://dx.doi.org/10.1186/cc3783

Ejemplares similares